Research Journal of Pharmaceutical Dosage Forms and Technology
  • Year: 2011
  • Volume: 3
  • Issue: 5

The Estimation of Maraviroc in Tablet dosage form by RP-HPLC.

  • Author:
  • L. Satyanarayana1,, S.V. Naidu2, M. Narasimha Rao2, C. Ayyanna2, Alok Kumar1
  • Total Page Count: 3
  • Page Number: 230 to 232

1Department of Pharmaceutical Chemistry, Omega College of Pharmacy, Edulabad, Ghatkesar, Ranga Reddy Dist., Hyderabad-500 034

2Centre for Biotechnology, Department of Chemical Engineering, College of Engineering (A), Andhra University, Vishakapatnam -530003

*Corresponding Author: L. Satyanarayana Department of Pharmaceutical Chemistry, Omega College of Pharmacy, Edulabad, Ghatkesar, Ranga Reddy Dist., Hyderabad-500 034. Email: satyadna_l@yahoo.co.in

Online published on 19 March, 2013.

Abstract

A simple, precise, rapid and accurate reverse phase HPLC method was developed for the estimation of Maraviroc in tablet dosage form. A RP Inertsil ODS-3V C-18, 250x4.6 mm, 5!m partical size, with mobile phase consisting of 0.02M Dipotasium hydrogen orthophosphate in water pH 2.5 with orthophosphoric acid and Acetonitrile in the ratio of 60:40 v/v was used. The flow rate was 0.8 ml/min and the effluents were monitored at 210 nm. The retention time was 4.330 min. The detector response was linear in the concentration of 80–240μg/ml. The respective linear regression equation being Y= 31018.059X + 44222.4. The limit of detection and limit of quantification was 0.2μg and 0.6μg/ml respectively. The percentage assay of Maraviroc was 99.42%. The method was validated by determining its accuracy, precision and system suitability.

The results of the study showed that the proposed RP-HPLC method is simple, rapid, precise and accurate, which is useful for the routine determination of Maraviroc in bulk drug and in its pharmaceutical dosage form.

Keywords

Maraviroc, RP-HPLC, Estimation, and Tablets